Description
CJC-1295 with DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH), engineered with a Drug Affinity Complex (DAC) to extend its half-life and stability.
In laboratory studies, it has been investigated for its interaction with growth hormone signaling pathways and its prolonged activity compared to non-modified variants. The DAC component allows for sustained binding, making it a commonly referenced compound in extended-duration studies.
Each vial is supplied in lyophilized form to maintain consistency and structural integrity.
- Modified GHRH analogue with extended duration
- Investigated in growth hormone signaling pathways
- DAC component supports prolonged activity
- Lyophilized for enhanced stability
- Consistent batch preparation
Reviews
There are no reviews yet.